4 completed. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Malignant Peritoneal Neoplasm: new trials by email Literature Review of Malignant Peritoneal Neoplasm trials Research Report on Malignant Peritoneal Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy Biospecimen Collection, Pain Assessment, Questionnaire Administration - Appendix Carcinoma, Carcinomatosis | Completed | M.D. Anderson Cancer Center | 24 | 2021-08-10 | 2024-02-13 | |
| Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Malignant Peritoneal Neoplasm, Malignant Retroperitoneal Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 26 | 2018-09-21 | 2025-05-22 |
| Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery Management of Therapy Complications Fitbit Zip (portable pedometer device), Questionnaire Administration, Quality-of-Life Assessment - Malignant Gastrointestinal Neoplasm, Malignant Peritoneal Neoplasm | Not applicable | Completed | Wake Forest University Health Sciences | 34 | 2015-03-01 | 2018-09-27 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers Bevacizumab, Laboratory Biomarker Analysis, Nab-paclitaxel - Cervical Adenocarcinoma, Cervical Adenosarcoma | Phase 1 | Completed | Mayo Clinic | 43 | 2014-02-24 | 2024-07-26 |
Appendiceal Neoplasms (1) · Carcinoma (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gastrointestinal Neoplasms (1) · Ovarian Neoplasms (1) · Peritoneal Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Gastrointestinal Diseases (2) · Abdominal Neoplasms (1) · Adnexal Diseases (1) · Cecal Diseases (1) · Cecal Neoplasms (1) · Colonic Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Bevacizumab (1) · CTLA-4 Antigen (1) · Disulfides (1) · Immunoglobulin G (1) · Ipilimumab (1) · Nivolumab (1) · Pharmacogenomic Variants (1) · Taxes (1)
M.D. Anderson Cancer Center (2) · Mayo Clinic (1) · Wake Forest University Health Sciences (1)
United States (4)
Amir A Jazaeri (1) · Clancy Clark (1) · Juan P Cata (1) · Matthew S. Block, M.D., Ph.D. (1)
P30CA012197 (1)